Update: 12.12.2022
Last week: 48 week 2022 (28.11.2022 - 04.12.2022)
Last full month: November 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 183 300 | 20.1% | 3.2% | 0 | 42 421 370 | 21.5% | 3.4% | 0 | 19.5% |
| MoM | 604 970 | -8.8% | 3.3% | -0.5 | 138 517 736 | -2.4% | 3.4% | -0.4 | 4.9% |
| YTD | 9 047 296 | -25.3% | 5.0% | -1.4 | 1 826 896 690 | -12.0% | 4.9% | -1 | -4.3% |
| MAT | 10 199 044 | -18.9% | 5.1% | -0.8 | 2 040 469 700 | -5.5% | 4.9% | -0.5 | -5.4% |
| DEXALGIN | |||||||||
| WoW | 16 832 | 7.5% | 0.3% | 0 | 8 453 417 | 7.5% | 1.1% | 0 | 7.9% |
| MoM | 67 963 | -21.8% | 0.3% | -0.1 | 33 907 140 | -21.4% | 1.1% | -0.3 | -3.7% |
| YTD | 1 505 293 | -10.0% | 0.6% | -0.1 | 647 725 943 | 1.9% | 1.8% | -0.1 | -1.0% |
| MAT | 1 672 182 | -9.0% | 0.6% | 0 | 712 969 190 | 2.3% | 1.8% | -0.1 | -2.7% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 56 268 | 1.1% | 41.0% | 0.2 | 31 180 919 | 1.3% | 47.6% | -0.6 | 0.5% |
| MoM | 240 711 | 0.5% | 41.3% | -1.5 | 131 026 847 | 4.0% | 48.3% | -0.8 | 4.1% |
| YTD | 4 067 445 | -16.4% | 53.9% | -12.4 | 2 080 766 312 | -6.5% | 59.6% | -11.1 | 2.9% |
| MAT | 4 483 812 | -15.6% | 54.5% | -11.6 | 2 280 278 571 | -5.5% | 60.2% | -10.2 | 2.3% |
| ESPUMISAN BABY | |||||||||
| WoW | 26 216 | 6.5% | 33.3% | -0.9 | 18 069 753 | 8.0% | 47.8% | -0.3 | 9.3% |
| MoM | 103 328 | 2.6% | 33.8% | 1.4 | 69 479 607 | 5.8% | 47.4% | 1.6 | -1.6% |
| YTD | 1 337 091 | -13.4% | 37.4% | -4.2 | 841 846 869 | -6.6% | 50.7% | -5.7 | -3.8% |
| MAT | 1 455 802 | -15.3% | 37.5% | -4.1 | 911 970 164 | -8.5% | 50.9% | -5.4 | -6.0% |
| FASTUM | |||||||||
| WoW | 15 863 | -7.5% | 0.9% | -0.1 | 9 144 135 | -6.3% | 2.2% | -0.2 | -0.1% |
| MoM | 72 086 | 12.1% | 0.9% | 0.1 | 40 966 576 | 12.7% | 2.4% | 0.3 | -1.3% |
| YTD | 980 240 | -24.1% | 1.1% | -0.4 | 512 068 384 | -14.0% | 2.5% | -0.6 | -0.1% |
| MAT | 1 073 610 | -25.0% | 1.1% | -0.3 | 557 076 453 | -15.1% | 2.5% | -0.6 | -1.8% |
| IODOMARIN | |||||||||
| WoW | 70 007 | 1.0% | 22.4% | -0.6 | 12 904 187 | 0.9% | 9.2% | -0.6 | 3.8% |
| MoM | 299 606 | -16.4% | 23.2% | -1 | 55 472 593 | -16.2% | 9.8% | -0.8 | -12.7% |
| YTD | 3 032 849 | 4.8% | 20.5% | 0 | 592 153 636 | 9.2% | 9.1% | -0.2 | 4.7% |
| MAT | 3 306 054 | 7.9% | 20.6% | 0.8 | 642 196 362 | 11.4% | 9.2% | 0.2 | 3.4% |
| LIOTON | |||||||||
| WoW | 17 331 | 1.5% | 1.8% | 0 | 20 208 786 | -0.5% | 4.4% | -0.1 | 1.1% |
| MoM | 72 321 | 5.9% | 1.8% | 0.2 | 83 457 879 | 9.9% | 4.3% | 0.5 | -4.0% |
| YTD | 1 192 116 | -25.2% | 2.3% | -0.5 | 1 236 681 799 | -6.0% | 4.6% | -1 | -7.5% |
| MAT | 1 291 301 | -25.0% | 2.3% | -0.5 | 1 324 119 783 | -6.3% | 4.7% | -0.9 | -8.5% |
| MEZYM | |||||||||
| WoW | 216 361 | -1.1% | 17.9% | -0.6 | 31 831 413 | -3.7% | 12.2% | -0.9 | 2.1% |
| MoM | 921 273 | 0.0% | 18.4% | -0.3 | 136 606 124 | -2.7% | 12.9% | -0.6 | 1.9% |
| YTD | 16 380 675 | -13.6% | 25.9% | -3 | 2 500 212 338 | -5.5% | 18.6% | -3.1 | -3.5% |
| MAT | 18 177 339 | -12.9% | 26.3% | -2.5 | 2 762 606 583 | -5.1% | 18.9% | -2.7 | -4.5% |
| MIG 400 | |||||||||
| WoW | 133 998 | 4.0% | 2.5% | -0.1 | 16 123 694 | 4.4% | 2.0% | 0 | 7.9% |
| MoM | 558 202 | -5.5% | 2.8% | -0.1 | 67 227 770 | -5.7% | 2.2% | -0.1 | -3.7% |
| YTD | 7 812 370 | -15.1% | 3.3% | -0.5 | 922 249 175 | -11.1% | 2.5% | -0.6 | -1.0% |
| MAT | 8 504 572 | -15.2% | 3.3% | -0.5 | 1 001 833 306 | -11.4% | 2.5% | -0.5 | -2.7% |
| PROSTAMOL | |||||||||
| WoW | 24 773 | 1.1% | 13.6% | -0.3 | 34 226 938 | 0.8% | 14.2% | -0.4 | 3.6% |
| MoM | 101 766 | -2.9% | 14.1% | -1.3 | 140 977 526 | -2.3% | 14.9% | -1.4 | 6.2% |
| YTD | 1 454 845 | -26.9% | 18.5% | -6.3 | 2 036 238 063 | -18.7% | 19.8% | -7.2 | -2.2% |
| MAT | 1 604 594 | -26.3% | 18.8% | -5.7 | 2 233 074 981 | -18.2% | 20.1% | -6.5 | -4.1% |
| RESPERO MYRTOL | |||||||||
| WoW | 31 404 | 22.6% | 7.5% | 0.8 | 15 947 459 | 23.2% | 8.1% | 0.8 | 10.2% |
| MoM | 102 019 | 2.1% | 7.0% | -0.6 | 51 471 720 | 5.2% | 7.5% | -0.4 | 11.1% |
| YTD | 1 150 608 | 83.1% | 8.3% | 3.6 | 544 722 222 | 85.9% | 8.4% | 3.3 | 3.9% |
| MAT | 1 268 994 | 87.7% | 8.4% | 3.8 | 596 587 401 | 89.0% | 8.4% | 3.5 | 2.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 9 047 296 | -25.3% | 5.0% | -1.4 | 1 826 896 690 | -12.0% | 4.9% | -1 | -4.3% |
| DEXALGIN | 1 505 293 | -10.0% | 0.6% | -0.1 | 647 725 943 | 1.9% | 1.8% | -0.1 | -1.0% |
| ESPUMISAN (ADULTS) | 4 067 445 | -16.4% | 53.9% | -12.4 | 2 080 766 312 | -6.5% | 59.6% | -11.1 | 2.9% |
| ESPUMISAN BABY | 1 337 091 | -13.4% | 37.4% | -4.2 | 841 846 869 | -6.6% | 50.7% | -5.7 | -3.8% |
| FASTUM | 980 240 | -24.1% | 1.1% | -0.4 | 512 068 384 | -14.0% | 2.5% | -0.6 | -0.1% |
| IODOMARIN | 3 032 849 | 4.8% | 20.5% | 0 | 592 153 636 | 9.2% | 9.1% | -0.2 | 4.7% |
| LIOTON | 1 192 116 | -25.2% | 2.3% | -0.5 | 1 236 681 799 | -6.0% | 4.6% | -1 | -7.5% |
| MEZYM | 16 380 675 | -13.6% | 25.9% | -3 | 2 500 212 338 | -5.5% | 18.6% | -3.1 | -3.5% |
| MIG 400 | 7 812 370 | -15.1% | 3.3% | -0.5 | 922 249 175 | -11.1% | 2.5% | -0.6 | -1.0% |
| PROSTAMOL | 1 454 845 | -26.9% | 18.5% | -6.3 | 2 036 238 063 | -18.7% | 19.8% | -7.2 | -2.2% |
| RESPERO MYRTOL | 1 150 608 | 83.1% | 8.3% | 3.6 | 544 722 222 | 85.9% | 8.4% | 3.3 | 3.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 10 199 044 | -18.9% | 5.1% | -0.8 | 2 040 469 700 | -5.5% | 4.9% | -0.5 | -5.4% |
| DEXALGIN | 1 672 182 | -9.0% | 0.6% | 0 | 712 969 190 | 2.3% | 1.8% | -0.1 | -2.7% |
| ESPUMISAN (ADULTS) | 4 483 812 | -15.6% | 54.5% | -11.6 | 2 280 278 571 | -5.5% | 60.2% | -10.2 | 2.3% |
| ESPUMISAN BABY | 1 455 802 | -15.3% | 37.5% | -4.1 | 911 970 164 | -8.5% | 50.9% | -5.4 | -6.0% |
| FASTUM | 1 073 610 | -25.0% | 1.1% | -0.3 | 557 076 453 | -15.1% | 2.5% | -0.6 | -1.8% |
| IODOMARIN | 3 306 054 | 7.9% | 20.6% | 0.8 | 642 196 362 | 11.4% | 9.2% | 0.2 | 3.4% |
| LIOTON | 1 291 301 | -25.0% | 2.3% | -0.5 | 1 324 119 783 | -6.3% | 4.7% | -0.9 | -8.5% |
| MEZYM | 18 177 339 | -12.9% | 26.3% | -2.5 | 2 762 606 583 | -5.1% | 18.9% | -2.7 | -4.5% |
| MIG 400 | 8 504 572 | -15.2% | 3.3% | -0.5 | 1 001 833 306 | -11.4% | 2.5% | -0.5 | -2.7% |
| PROSTAMOL | 1 604 594 | -26.3% | 18.8% | -5.7 | 2 233 074 981 | -18.2% | 20.1% | -6.5 | -4.1% |
| RESPERO MYRTOL | 1 268 994 | 87.7% | 8.4% | 3.8 | 596 587 401 | 89.0% | 8.4% | 3.5 | 2.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 183 300 | 20.1% | 3.2% | 0 | 42 421 370 | 21.5% | 3.4% | 0 | 19.5% |
| DEXALGIN | 16 832 | 7.5% | 0.3% | 0 | 8 453 417 | 7.5% | 1.1% | 0 | 7.9% |
| ESPUMISAN (ADULTS) | 56 268 | 1.1% | 41.0% | 0.2 | 31 180 919 | 1.3% | 47.6% | -0.6 | 0.5% |
| ESPUMISAN BABY | 26 216 | 6.5% | 33.3% | -0.9 | 18 069 753 | 8.0% | 47.8% | -0.3 | 9.3% |
| FASTUM | 15 863 | -7.5% | 0.9% | -0.1 | 9 144 135 | -6.3% | 2.2% | -0.2 | -0.1% |
| IODOMARIN | 70 007 | 1.0% | 22.4% | -0.6 | 12 904 187 | 0.9% | 9.2% | -0.6 | 3.8% |
| LIOTON | 17 331 | 1.5% | 1.8% | 0 | 20 208 786 | -0.5% | 4.4% | -0.1 | 1.1% |
| MEZYM | 216 361 | -1.1% | 17.9% | -0.6 | 31 831 413 | -3.7% | 12.2% | -0.9 | 2.1% |
| MIG 400 | 133 998 | 4.0% | 2.5% | -0.1 | 16 123 694 | 4.4% | 2.0% | 0 | 7.9% |
| PROSTAMOL | 24 773 | 1.1% | 13.6% | -0.3 | 34 226 938 | 0.8% | 14.2% | -0.4 | 3.6% |
| RESPERO MYRTOL | 31 404 | 22.6% | 7.5% | 0.8 | 15 947 459 | 23.2% | 8.1% | 0.8 | 10.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 604 970 | -8.8% | 3.3% | -0.5 | 138 517 736 | -2.4% | 3.4% | -0.4 | 4.9% |
| DEXALGIN | 67 963 | -21.8% | 0.3% | -0.1 | 33 907 140 | -21.4% | 1.1% | -0.3 | -3.7% |
| ESPUMISAN (ADULTS) | 240 711 | 0.5% | 41.3% | -1.5 | 131 026 847 | 4.0% | 48.3% | -0.8 | 4.1% |
| ESPUMISAN BABY | 103 328 | 2.6% | 33.8% | 1.4 | 69 479 607 | 5.8% | 47.4% | 1.6 | -1.6% |
| FASTUM | 72 086 | 12.1% | 0.9% | 0.1 | 40 966 576 | 12.7% | 2.4% | 0.3 | -1.3% |
| IODOMARIN | 299 606 | -16.4% | 23.2% | -1 | 55 472 593 | -16.2% | 9.8% | -0.8 | -12.7% |
| LIOTON | 72 321 | 5.9% | 1.8% | 0.2 | 83 457 879 | 9.9% | 4.3% | 0.5 | -4.0% |
| MEZYM | 921 273 | 0.0% | 18.4% | -0.3 | 136 606 124 | -2.7% | 12.9% | -0.6 | 1.9% |
| MIG 400 | 558 202 | -5.5% | 2.8% | -0.1 | 67 227 770 | -5.7% | 2.2% | -0.1 | -3.7% |
| PROSTAMOL | 101 766 | -2.9% | 14.1% | -1.3 | 140 977 526 | -2.3% | 14.9% | -1.4 | 6.2% |
| RESPERO MYRTOL | 102 019 | 2.1% | 7.0% | -0.6 | 51 471 720 | 5.2% | 7.5% | -0.4 | 11.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG 400"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs